Publicaciones

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

New antiretroviral drugs and approaches to HIV treatment.

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.